Paid Clinical Trials New Hampshire
Discover 326 paid clinical trials in New Hampshire. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative ColitisA Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
Sponsor:
Pfizer
Location:
Code:
NCT05287126
Conditions
Ulcerative Colitis
Eligibility Criteria
Sex: All
Age: 12 - 17
Healthy Volunteers: Not accepted
Interventions
Etrasimod
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABGAnticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
Sponsor:
Icahn School of Medicine at Mount Sinai
Location:
Code:
NCT04045665
Conditions
Atrial Fibrillation
Stroke
Bleeding
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Antiplatelet-only strategy
Oral Anticoagulant plus background antiplatelet therapy
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Sponsor:
NRG Oncology
Location:
Code:
NCT05879926
Conditions
Breast Cancer
Eligibility Criteria
Sex: Female
Age: 18 - 60
Healthy Volunteers: Not accepted
Interventions
Ovarian Function Suppression + Aromatase Inhibitor
Adjuvant Chemotherapy + Ovarian Function Suppression
A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade GliomaA Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma
Sponsor:
National Cancer Institute (NCI)
Location:
Code:
NCT03871257
Conditions
Low Grade Glioma
Neurofibromatosis Type 1
Visual Pathway Glioma
Eligibility Criteria
Sex: All
Age: 2 - 21
Healthy Volunteers: Not accepted
Interventions
Carboplatin
Magnetic Resonance Imaging
Quality-of-Life Assessment
Questionnaire Administration
Selumetinib Sulfate
Post-Surgical Stereotactic Radiotherapy (SRT) Versus GammaTile-ROADS (Radiation One and Done Study)Post-Surgical Stereotactic Radiotherapy (SRT) Versus GammaTile-ROADS (Radiation One and Done Study)
Sponsor:
GT Medical Technologies, Inc.
Location:
Code:
NCT04365374
Conditions
Brain Metastases
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Gamma Tile-Surgically Targeted Radiation Therapy (STaRT)
Stereotactic Radiation Therapy
Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid ArthritisStudy to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis
Sponsor:
AbbVie
Location:
Code:
NCT05814627
Conditions
Rheumatoid Arthritis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Upadacitinib
Adalimumab
Upadacitinib Matching Placebo
Adalimumab Matching Placebo
A Study of AP-CD/LD in Fluctuating Parkinson's Disease Patients Who Completed IN 11 004A Study of AP-CD/LD in Fluctuating Parkinson's Disease Patients Who Completed IN 11 004
Sponsor:
Intec Pharma Ltd.
Location:
Code:
NCT02615873
Conditions
Parkinson's Disease
Eligibility Criteria
Sex: All
Age: 30 - 70+
Healthy Volunteers: Not accepted
Interventions
Accordion Pill™ Carbidopa/Levodopa
SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTNSPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN
Sponsor:
Medtronic Vascular
Location:
Code:
NCT05198674
Conditions
Hypertension
Vascular Diseases
Cardiovascular Diseases
Chronic Kidney Diseases
Diabetes Mellitus
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Renal Denervation (Symplicity Spyral™)
PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening IschemiaPROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia
Sponsor:
LimFlow, Inc.
Location:
Code:
NCT05313165
Conditions
Critical Limb Ischemia
Chronic Limb-Threatening Ischemia
Peripheral Arterial Disease
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
LimFlow Stent Graft System
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With OsteosarcomaThoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Sponsor:
Children's Oncology Group
Location:
Code:
NCT05235165
Conditions
Metastatic Malignant Neoplasm in the Lung
Metastatic Osteosarcoma
Osteosarcoma
Eligibility Criteria
Sex: All
Age: 0 - 50
Healthy Volunteers: Not accepted
Interventions
Biospecimen Collection
Computed Tomography
Questionnaire Administration
Thoracoscopy
Thoracotomy
Popular cities in New Hampshire
New Hampshire stands out as a key location for clinical trials, thanks to its strong healthcare network and renowned medical research institutions. Dartmouth-Hitchcock Medical Center and the Geisel School of Medicine at Dartmouth are at the forefront of innovative studies, particularly in areas such as cancer, cardiovascular diseases, and neurological conditions.
With access to cutting-edge medical technology and expertise, these institutions contribute significantly to groundbreaking advancements in medical research.
Why choose New Hampshire for clinical trials?
New Hampshire presents unique opportunities for individuals participating in clinical trials. The state's blend of urban and rural populations provides a diverse pool of participants, enhancing the accuracy and relevance of research outcomes. New Hampshire is also known for its innovative approach to healthcare, with a strong emphasis on medical advancements and collaboration among its leading research institutions.
By choosing to participate in a clinical trial in New Hampshire, individuals contribute to critical medical research while benefiting from a well-established and supportive clinical trial infrastructure. This not only ensures high-quality care but also plays a crucial role in shaping the future of medical treatments and healthcare advancements.
Common conditions studied in New Hampshire
New Hampshire is home to a variety of clinical trials focusing on medical conditions and diseases that reflect both its expertise and population health needs.
Neurological disorders
With an aging population, New Hampshire is heavily involved in researching neurological disorders like Alzheimer’s and Parkinson’s diseases. Clinical trials in the state are investigating early diagnosis techniques, such as biomarkers and advanced imaging, as well as new medications that aim to slow or stop disease progression. The region's research institutions are also exploring lifestyle interventions and cognitive therapies to improve the quality of life for patients suffering from neurodegenerative diseases.
Cardiovascular disease
Cardiovascular research is a key area of focus for New Hampshire’s medical institutions, with trials investigating treatments for conditions like heart disease, hypertension, and stroke. Researchers in the state are testing new drug therapies, advanced surgical techniques, and non-invasive devices to prevent heart attacks and strokes.
Additionally, many studies explore the role of diet, exercise, and genetic factors in improving heart health, contributing to more personalized approaches to cardiovascular care.
Cancer
New Hampshire is home to pioneering cancer research, especially at the Dartmouth-Hitchcock Norris Cotton Cancer Center, one of the nation's top cancer institutes. Clinical trials in oncology explore groundbreaking treatments for a wide range of cancers, including breast, lung, colorectal, and prostate cancer.
Researchers in New Hampshire focus primarily on advancing immunotherapy, which harnesses the body’s immune system to fight cancer, as well as targeted therapies that specifically attack cancer cells without damaging surrounding healthy tissue. These trials offer patients access to innovative treatments that are not yet widely available.
Chronic respiratory disorders
New Hampshire is also a hub for clinical trials addressing chronic respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD). The state’s researchers are investigating new medications, inhalation devices, and lifestyle interventions aimed at managing these chronic conditions more effectively. With a focus on improving lung function and quality of life, these trials seek to reduce hospitalizations and flare-ups, which are common in severe respiratory illnesses.
Mental health conditions
Mental health is a growing focus in New Hampshire’s clinical research landscape. Clinical trials are being conducted to evaluate new medications, psychotherapies, and integrative treatment options for conditions like depression, anxiety, and PTSD.
Given the state’s strong support for veterans and active-duty personnel, PTSD research is a particularly important area of focus, with trials looking into trauma-focused therapies, neurostimulation techniques, and innovative medication combinations aimed at reducing symptoms and improving mental well-being.
Local regulations and guidelines
In New Hampshire, clinical trials must adhere to strict federal regulations and state guidelines designed to protect participants and ensure ethical research practices. The U.S. Food and Drug Administration (FDA) and the Department of Health and Human Services (HHS) govern the oversight of clinical trials, including requirements for Institutional Review Board (IRB) approval. The IRB ensures all trials prioritize participant safety, informed consent, and ethical research design.
New Hampshire also follows guidelines set by the Office for Human Research Protections (OHRP), which enforces compliance with federal laws like the Common Rule. This includes securing informed consent from participants, maintaining data privacy and confidentiality, and providing ongoing monitoring throughout the trial. Researchers in the state must also comply with state-specific laws, particularly regarding privacy and the handling of sensitive health data, ensuring that all clinical research is conducted with the highest standards of safety and integrity.
Benefits of participating in clinical trials
Participating in a clinical trial offers individuals the unique opportunity to access cutting-edge treatments and therapies before they are broadly available, especially for those whose conditions haven't responded to standard care. Throughout the trial, participants receive expert care, with dedicated healthcare professionals closely monitoring their progress to ensure safety and effectiveness.
Additionally, clinical trial participation is vital for advancing medical research, often leading to breakthrough treatments and improved healthcare strategies. By joining, individuals not only benefit from early access to innovative therapies but also contribute to the advancement of science, helping shape the future of healthcare and improve patient outcomes globally.
Worried about the risks of participating in a clinical trial? Read our comprehensive guide to gain insights into the potential outcomes of participating. Learn about potential risks, benefits, and safety considerations to make an informed decision about your participation in a clinical trial.
How to enroll in a clinical trial in New Hampshire
Enrolling in a clinical trial through our platform is a straightforward and user-friendly process. Here's how to get started:
- Identify your trial: Use our intuitive search bar or filter options to locate clinical trials specific to requirements. This first step simplifies the process of finding relevant research studies tailored to your needs.
- Select your preferred location: To find trials conveniently located near you, simply input your preferred location into the dedicated filter bar on the left-hand side of the page.
- Explore study details: For in-depth information about each study, simply click the “Learn More” button. This will provide you with comprehensive details about the trial, including objectives, procedures, and eligibility criteria.
- Complete the health profile: After clicking on the “Get started” button you will be taken to our efficient 5-step application process to provide important health information. This helps us match you with the clinical trial that best fits your needs.
- Submit the application: After completing the application, send it in. A clinical trial coordinator will review it and contact you regarding the possibility of participation.